Merck, Sun Pharma secure legal victory as Indian court penalizes generic-patent infringer
By Freny Patel ( January 26, 2026, 00:26 GMT | Insight) -- Merck and Sun Pharma have secured a legal victory after an Indian court penalized patent infringement of Sitagliptin, reinforcing legal protections for pharmaceutical innovation against unauthorized generic manufacturing.Merck Sharp & Dohme and its Indian licensee Sun Pharmaceutical Industries have scored a decisive legal victory, including a financial award, after an Indian court found a domestic manufacturer liable for infringing the patent for the blockbuster diabetes drug, Sitagliptin....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.